Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma

14 Jun 2022

Abstract excerpt

BACKGROUND: This study clarified whether EMT-related genes can predict immunotherapy efficacy and overall survival in patients with HCC. METHODS: The RNA-sequencing profiles and patient information of 370 samples were derived from the Cancer Genome Atlas (TCGA) dataset, and EMT-related genes were obtained from the Molecular Signatures database. The signature model was constructed using the least absolute...

Topics

Join the communities discussing this publication.

Cancer Immunotherapy and Biomarkers
Ferroptosis and cancer prognosis
Immune cells in cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35699863
DOI: 10.1007/s12072-022-10354-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinomaPMID 35699863Read ↗

Construction and validation of a novel signature based on epithelial-mesenchymal transition–related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironmentSemantic proximity Read ↗

Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.Semantic proximity Read ↗

Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature for Hepatocellular CarcinomaSemantic proximity Read ↗

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomesSemantic proximity Read ↗

Development of a prognostic model based on immunogenomic landscape analysis of hepatocellular carcinomaSemantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinomaSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Construction of a Six Immune-Related lncRNAs Signature to Predict Outcome, Immune Cell Infiltration and Immunotherapy Response in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.